Volume 10, Number 11—November 2004

Research

Evaluating Human Papillomavirus Vaccination Programs

Al V. Taira*, Christopher P. Neukermans†, and Gillian D. Sanders†‡ 

Author affiliations: *Stanford School of Medicine, Stanford, California, USA; †Stanford University, Stanford, California, USA; ‡Duke University, Durham, North Carolina, USA

Main Article

Figure A1

Figure A1. . Prevalence of HPV-16 and HPV-18. A) HPV-16 prevalence in women. B) HPV-16 prevalence in men. C) HPV-18 prevalence in women. D) HPV-18 prevalence in men.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.